Open AccessToxicities, dose reduction and delay of docetaxel and paclitaxel chemotherapy in breast cancer without distant metastases
Author(s) -
SangUk Woo,
Wooyoung Kim,
JaeHong Seo,
GilSoo Son,
Jae-Bok Lee,
JeoungWon Bae
Publication year - 2011
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.92004
Subject(s) - medicine , docetaxel , febrile neutropenia , neutropenia , breast cancer , cyclophosphamide , taxane , gastroenterology , oncology , regimen , chemotherapy , cancer , surgery
Docetaxel and paclitaxel are likely to have different toxicity profiles, dose reduction and delays despite their similar medical results in breast cancer patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom